Literature DB >> 1089400

Amine precursors and depression.

J Mendels, J L Stinnett, D Burns, A Frazer.   

Abstract

The amino acid precursors, levodopa and L-tryptophan, were given to a group of hospitalized depressed patients in a double-blind placebo controlled study. Relatively large doses were not associated with sufficient clinical improvement to allow the patients to leave the hospital. Previous studies using the precursor-load strategy have produced conflicting findings on the use of these compounds for depressed patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089400     DOI: 10.1001/archpsyc.1975.01760190024002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  11 in total

1.  Anti-depressant potentiation of 5-hydroxytryptophan by L-deprenyl, an MAO "type B" inhibitor.

Authors:  J Mendlewicz; M B Youdim
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

Review 2.  The 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouse.

Authors:  Jacob P R Jacobsen; Ivan O Medvedev; Marc G Caron
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2012-09-05       Impact factor: 6.237

Review 3.  Tryptophan antidepressant 'physiological sedative': fact or fancy?

Authors:  A J Cooper
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

Review 4.  An excitatory synapse hypothesis of depression.

Authors:  Scott M Thompson; Angy J Kallarackal; Mark D Kvarta; Adam M Van Dyke; Tara A LeGates; Xiang Cai
Journal:  Trends Neurosci       Date:  2015-04-14       Impact factor: 13.837

Review 5.  A meta-analysis of the response to chronic L-dopa in patients with schizophrenia: therapeutic and heuristic implications.

Authors:  George E Jaskiw; Anand P Popli
Journal:  Psychopharmacology (Berl)       Date:  2003-12-11       Impact factor: 4.530

6.  Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing meals.

Authors:  E Melamed; B Glaeser; J H Growdon; R J Wurtman
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

7.  Fluvoxamine-a new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients.

Authors:  B Saletu; M Schjerve; J Grünberger; H Schanda; O H Arnold
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

8.  Noradrenaline, depressive illness, and the action of amitriptyline.

Authors:  K Ghose; A Coppen
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

Review 9.  Serotonin and depression: a disconnect between the advertisements and the scientific literature.

Authors:  Jeffrey R Lacasse; Jonathan Leo
Journal:  PLoS Med       Date:  2005-11-08       Impact factor: 11.069

10.  5-HTP efficacy and contraindications.

Authors:  Marty Hinz; Alvin Stein; Thomas Uncini
Journal:  Neuropsychiatr Dis Treat       Date:  2012-07-19       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.